Dragerwerk AG & Co. KGaA develops equipment and solutions in the fields of medical and safety technology in Germany and internationally. The company’s Medical division develops, produces, and markets system solutions, equipment, and services for acute point of care, including perioperative care, critical care, neonatal care, emergency care, and perinatal care. It offers products for therapy, monitoring, information management, and process support; products for ventilation, anesthetics, and warming therapy, as well as related accessories and consumables; and system products, such as integrated IT solutions for the operating room and gas management systems. This division’s product range covers anesthesia workstations, ventilation equipment for intensive care, emergency and mobile ventilation units, warming therapy equipment for infants, and patient monitoring equipment. The company’s Safety division develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in chemical, petrochemical, and mining industries, as well as public sector, such as fire services, police, and disaster protection. Its product portfolio comprises stationary and mobile gas detection systems, personal protective equipment, professional diving systems, and alcohol and drug testing devices. This division also provides various training and services, as well as handles projects, such as fire training systems. Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lubeck, Germany.
draegerwerk ag (DRW8:Xetra)
Moislinger Allee 53-55
Phone: 49 451 882 3998
Fax: 49 451 882 3944www.draeger.com
|Dehaier Medical Systems Ltd||$2.78 USD||+0.005|
|Lifeloc Technologies Inc||$15.99 USD||0.00|
|MSA Safety Inc||$44.90 USD||+0.20|
|Omnicell Inc||$34.37 USD||-0.73|
|Riken Keiki Co Ltd||¥1,460 JPY||+54.00|
|View Industry Companies|
Sponsored Financial Commentaries
To contact DRAEGERWERK AG, please visit www.draeger.com. Company data is provided by Capital IQ. Please use this form to report any data issues.